Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3903 |  RLYB Rallybio Corporation - Common Stock | 16.99 USD | +0.35% | +1.19% | +1.13% | +2989.09% | 90.23 M USD | ||
| 3904 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 0.48 USD | +2.13% | -14.29% | -60.00% | -74.87% | 90.19 M USD | ||
| 3907 |  CLLS Cellectis S.A. - American Depositary Shares | 1.25 USD | -6.72% | -13.79% | -59.55% | -70.24% | 89.69 M USD | ||
| 3908 |  PYPD PolyPid Ltd. - Ordinary Shares | 4.90 USD | -1.01% | -10.75% | -5.77% | +49.39% | 89.20 M USD | ||
| 3912 |  ICCC ImmuCell Corporation - Common Stock | 9.75 USD | +0.62% | +1.35% | -0.91% | +42.96% | 88.55 M USD | ||
| 3914 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 0.71 USD | -6.58% | -13.41% | -33.02% | -66.19% | 88.39 M USD | ||
| 3926 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.90 USD | -4.26% | -2.17% | -9.09% | -55.00% | 85.58 M USD | ||
| 3927 |  NRXS Neuraxis, Inc. Common Stock | 6.80 USD | -0.58% | -6.21% | +20.14% | +25.23% | 85.39 M USD | ||
| 3940 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.06 USD | -2.75% | -12.40% | +0.95% | -55.46% | 82.46 M USD | ||
| 3945 |  PMN ProMIS Neurosciences Inc. - Common Shares | 9.15 USD | +0.33% | -3.38% | -33.16% | +1659.62% | 82.05 M USD | ||
| 3959 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.87 USD | -0.53% | -8.78% | -7.88% | -5.08% | 80.14 M USD | ||
| 3964 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.49 USD | -0.67% | -14.86% | +8.76% | +7.97% | 79.65 M USD | ||
| 3968 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.15 USD | +2.68% | -1.71% | -3.36% | -35.75% | 79.09 M USD | ||
| 3980 |  MNOV MediciNova, Inc. - Common Stock | 1.54 USD | -4.35% | -8.88% | -12.99% | +25.20% | 75.80 M USD | ||
| 3997 |  NTRB Nutriband Inc. - Common Stock | 6.05 USD | -10.50% | -18.90% | +5.03% | -14.79% | 73.54 M USD | ||
| 4002 |  OKYO OKYO Pharma Limited - American Depositary Shares | 1.39 USD | -2.80% | +4.51% | -0.71% | -34.43% | 72.95 M USD | ||
| 4017 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.18 USD | +0.97% | -13.64% | -17.39% | -30.56% | 71.81 M USD | ||
| 4020 |  CING Cingulate Inc. - Common Stock | 4.88 USD | +0.21% | +1.88% | -5.61% | -20.78% | 70.96 M USD | ||
| 4023 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.62 USD | -2.99% | -7.43% | -5.81% | -23.58% | 70.70 M USD | ||
| 4025 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.16 USD | 0.00% | -4.13% | -14.07% | -44.23% | 70.56 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |